The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...

These results suggest that fluctuating cholesterol, measured annually, may be a new biomarker for identifying people at risk of dementia. HealthDay News — Variability in total cholesterol (TC ...

Getty Images Uché Blackstock, MD, is the first Black mother-daughter legacy at Harvard Medical School. At the 2024 DNPs of Color annual meeting, Dr Uché Blackstock shares her perspective on ...

The researchers found that after 3 years of follow-up, time to recurrence was lower for participants assigned to aspirin versus placebo. A similar trend was seen for disease-free survival hazard ...

Significant dose-effect seen between flossing frequency and reduction in incident ischemic stroke. HealthDay News — Dental flossing is associated with a lower risk for ischemic and cardioembolic ...

Study participants cite historical exploitation, rapid vaccine development, and coercive messaging as primary reasons for COVID-19 vaccine hesitancy. Complex and deeply rooted factors, including ...

Source: Getty Images “Diversity in clinical trials is not only an ethical imperative; it is also good science. It allows us to understand how treatments affect different populations and how we ...

Following an executive order from President Donald Trump, the HHS removed all web pages that reference a variety of topics including LGBTQ+ and adolescent health. Web pages pertaining to topics ...

Lawmakers pressed RFK Jr, a longtime vaccine critic, on his qualifications to oversee HHS, a $1.7 trillion agency that oversees Medicare, Medicaid, funding for medical research, public health ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).